로딩 중…
지수 로딩 중…
위더스제약
330350· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩8,860+13.59%
2026-06-19
Price Chart
위더스제약+12.87%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 116.95B KRW |
| Revenue | 108.89B KRW |
| Net Income | -120.3M KRW |
| Total Assets | 142.60B KRW |
| Net Assets | 101.98B KRW |
| Employees | 218 |
| Value | |
| P/B | 1.15x |
| P/S | 1.07x |
| FCF Yield | 4.69% |
| Profitability | |
| ROE | -0.12% |
| ROA | -0.08% |
| Op. Margin | -0.42% |
| Revenue Growth | 9.50% |
| Earnings Growth | 141.19% |
| Financial Health | |
| Debt Ratio | 139.83% |
| Total Debt | 20.75B KRW |
| FCF | 5.48B KRW |
| Cash | 19.20B KRW |
| Current Ratio | 2.00x |
| Dividend | |
| Div. Yield | 1.28% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | 12.87% |
| 1M Return | 19.73% |
| From 52W High | -25.86% |
| 1Y MDD | -46.65% |
| Trading | |
| Volume | 7,554,707 shares |
| Foreign Own. | 3.69% |
| Per Share | |
| EPS | 552 KRW |
| BPS | 7,726 KRW |
Company Info
Withus Pharmaceutical, headquartered in Seocho-gu, Seoul, was established in 2004 and listed on KOSDAQ in 2020, with its primary business being the production and sale of specialized medicines. The company demonstrates strengths in cardiovascular drugs, operates cephalosporin antibiotic production facilities, and engages in Contract Manufacturing Organization (CMO) services. To expand its market share in aging population and chronic disease markets, Withus Pharmaceutical is strengthening its product lineup and pharmaceutical pipeline. It is also enhancing capabilities by securing manufacturing technologies through strategic collaborations.